Yoshitaka Morita

3.5k total citations
105 papers, 2.7k citations indexed

About

Yoshitaka Morita is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Yoshitaka Morita has authored 105 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 28 papers in Immunology and 22 papers in Oncology. Recurrent topics in Yoshitaka Morita's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (10 papers) and Cytokine Signaling Pathways and Interactions (10 papers). Yoshitaka Morita is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (10 papers) and Cytokine Signaling Pathways and Interactions (10 papers). Yoshitaka Morita collaborates with scholars based in Japan, United States and Canada. Yoshitaka Morita's co-authors include Naoki Kashihara, Masahiro Yamamura, Hirofumi Makino, Seishi Harada, Masanori Kawashima, Hideyuki Okamoto, David A. Fox, Tetsushi Aita, Takeo Sakuta and Minoru Satoh and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yoshitaka Morita

99 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshitaka Morita Japan 26 1.0k 775 659 608 296 105 2.7k
Hoon‐Suk Cha South Korea 30 698 0.7× 1.1k 1.4× 725 1.1× 406 0.7× 344 1.2× 147 2.8k
Toru Mima Japan 23 764 0.8× 941 1.2× 676 1.0× 579 1.0× 377 1.3× 52 2.5k
Shin‐ya Kawashiri Japan 27 745 0.7× 1.3k 1.7× 642 1.0× 374 0.6× 330 1.1× 223 3.0k
Masahiro Yamamura Japan 27 1.4k 1.3× 971 1.3× 1.1k 1.7× 562 0.9× 469 1.6× 89 3.4k
Kunihiro Ichinose Japan 31 1.2k 1.2× 1.3k 1.6× 773 1.2× 316 0.5× 248 0.8× 188 3.1k
Gurtej S. Cheema United States 24 1.2k 1.2× 1.3k 1.7× 351 0.5× 266 0.4× 283 1.0× 26 2.9k
Chul‐Soo Cho South Korea 29 675 0.7× 848 1.1× 750 1.1× 347 0.6× 224 0.8× 73 2.4k
Satoshi Yamasaki Japan 32 793 0.8× 775 1.0× 606 0.9× 582 1.0× 564 1.9× 188 3.1k
Ping Zhu China 34 1.8k 1.7× 1.2k 1.5× 1.4k 2.1× 532 0.9× 380 1.3× 142 3.7k
Seung Min Jung South Korea 27 508 0.5× 963 1.2× 549 0.8× 288 0.5× 248 0.8× 150 2.4k

Countries citing papers authored by Yoshitaka Morita

Since Specialization
Citations

This map shows the geographic impact of Yoshitaka Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitaka Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitaka Morita more than expected).

Fields of papers citing papers by Yoshitaka Morita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitaka Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitaka Morita. The network helps show where Yoshitaka Morita may publish in the future.

Co-authorship network of co-authors of Yoshitaka Morita

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitaka Morita. A scholar is included among the top collaborators of Yoshitaka Morita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitaka Morita. Yoshitaka Morita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishimura, Yasumitsu, et al.. (2025). NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors. Lara D. Veeken. 64(10). 5404–5412. 1 indexed citations
2.
Nakano, Kazuhisa, Sumie Hiramatsu, Shoko Tsuji, et al.. (2025). Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry. Journal of Clinical Medicine. 14(5). 1553–1553.
3.
Morizane, Shin, Sumie Hiramatsu, Kota Tachibana, et al.. (2022). Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation. International Journal of Molecular Sciences. 23(8). 4312–4312. 25 indexed citations
4.
Hirano, Tôru, Shuhei Okazaki, Yoshiki Yagita, et al.. (2022). Heterogeneity of Stroke in Patients with Systemic Lupus Erythematosus. Internal Medicine. 61(20). 3045–3052. 5 indexed citations
5.
Mukai, Tomoyuki, Mitsuaki Ono, Mizuho Kittaka, et al.. (2021). Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model. Oral Diseases. 29(3). 1089–1101. 3 indexed citations
6.
Mukai, Tomoyuki, et al.. (2020). Severe oral stomatitis due to reactivation of herpes simplex virus type 1 in a methotrexate-treated patient with dermatomyositis. Immunological Medicine. 44(1). 56–60. 7 indexed citations
7.
Yamamoto, Takenobu, et al.. (2019). Japanese Spotted Fever: A Rare Cause of Arthritis. Internal Medicine. 58(14). 2117–2118. 2 indexed citations
8.
Morita, Yoshitaka, et al.. (2019). Tuberculous fasciitis in a patient with systemic lupus erythematosus. BMJ Case Reports. 12(7). e230845–e230845.
9.
Morita, Yoshitaka. (2018). Treatment Update on Rheumatoid Arthritis. The Japanese Journal of Rehabilitation Medicine. 55(4). 334–339. 1 indexed citations
10.
Nishimura, Hirotake, et al.. (2018). Necrosis of the gastrocnemius muscle in microscopic polyangiitis. BMJ Case Reports. 2018. bcr–2017. 5 indexed citations
11.
Kurose, Koji, et al.. (2017). Nivolumab-induced polyarthritis. BMJ Case Reports. 2017. bcr–2017. 3 indexed citations
13.
Morita, Yoshitaka, et al.. (2008). Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study. Modern Rheumatology. 18(4). 379–384. 17 indexed citations
14.
Gupta, Raj, Yoshitaka Morita, Xiaogang He, et al.. (2001). Effector Function of Resting T Cells: Activation of Synovial Fibroblasts. The Journal of Immunology. 166(4). 2270–2275. 90 indexed citations
15.
Morita, Yoshitaka, Jian-Min Yang, Raj Gupta, et al.. (2001). Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. Journal of Clinical Investigation. 107(10). 1275–1284. 165 indexed citations
16.
Yoshida, Hiroshi, et al.. (2000). [A case of microscopic polyarteritis nodosa associated with autoimmune hepatitis complicated with rheumatoid arthritis and chronic thyroiditis].. PubMed. 97(7). 925–9. 2 indexed citations
17.
Morita, Yoshitaka, Masahiro Yamamura, Keiichiro Nishida, et al.. (1998). Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis & Rheumatism. 41(2). 306–314. 95 indexed citations
18.
Hata, Yasuhiro, et al.. (1998). Peripheral insertion of a central venous access device under fluoroscopic guidance using a Peripherally Accessed System (PAS) port in the forearm. CardioVascular and Interventional Radiology. 21(3). 230–233. 19 indexed citations
19.
Morita, Yoshitaka, Naoki Kashihara, Masayuki Yamamura, et al.. (1998). Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation. Annals of the Rheumatic Diseases. 57(2). 122–124. 23 indexed citations
20.
Morita, Yoshitaka, et al.. (1972). ERYTHROCYTE DEFORMATION AS A SIGN OF RENAL HOMOGRAFT REJECTION. Transplantation. 14(6). 683–688. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026